🟢 EIQ.AX is trading 27% up today on A$20M Pro Medicus funding and US partnership

EIQ.AX is trading approximately 27% higher at A$1.57 following the announcement of a strategic funding and U.S. commercial partnership with Pro Medicus.

• The agreement includes up to A$20 million in secured convertible notes, materially strengthening the company's capital position.
• A proposed reseller arrangement will allow Pro Medicus to market Echo IQ’s AI cardiology products through its established U.S. healthcare customer base.
• Investors are repricing the stock on significantly improved funding visibility and expanded distribution reach for U.S. commercialisation.